NASDAQ:CMMB

Chemomab Drops After Board Changes and CEO Stock Purchase
····

Chemomab Drops After Board Changes and CEO Stock Purchase

Chemomab Therapeutics’ shares fell 6.5% to $1.74 on Nasdaq Tuesday after a regulatory filing showed board changes, with Gwen Melincoff joining and two directors resigning. CEO Adi Mor George bought nearly $20,250 in shares last week. Cash stood at $8 million on March 31, enough to fund operations into early 2027. The company is advancing nebokitug for primary sclerosing cholangitis amid rising competition.
June 2, 2026

Stock Market Today

  • Top ASX Dividend Shares to Buy: Dexus Industria REIT and Nick Scali Ltd
    June 2, 2026, 8:00 PM EDT. Dexus Industria REIT (ASX: DXI) and Nick Scali Ltd (ASX: NCK) stand out as attractive dividend shares on the Australian Securities Exchange (ASX). Dexus Industria REIT, invested in industrial warehouses, projects a FY26 distribution yield around 7%, trading at a roughly 30% discount to its net tangible asset value of $3.39. Nick Scali, a furniture retailer, reported strong FY26 half-year growth with revenue up 7.2% and net profit rising 23.1%, increasing its interim dividend by 30%. It is forecast to offer a grossed-up dividend yield of about 7.1% including franking credits. Both companies face challenges from high interest rates and economic shifts but offer long-term value and reliable income amid current market volatility.